UK markets open in 5 hours 6 minutes

Merck & Co., Inc. (0QAH.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
89.70+0.19 (+0.22%)
At close: 07:10PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.34
52-week change 3N/A
S&P500 52-week change 3-16.03%
52-week high 389.48
52-week low 389.12
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 82.53B
% held by insiders 10.11%
% held by institutions 176.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.68
Trailing annual dividend yield 32.99%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin 29.00%
Operating margin (ttm)34.91%

Management effectiveness

Return on assets (ttm)12.61%
Return on equity (ttm)43.42%

Income statement

Revenue (ttm)57.17B
Revenue per share (ttm)22.61
Quarterly revenue growth (yoy)28.00%
Gross profit (ttm)35.46B
EBITDA 23.48B
Net income avi to common (ttm)16.64B
Diluted EPS (ttm)5.59
Quarterly earnings growth (yoy)155.30%

Balance sheet

Total cash (mrq)10.13B
Total cash per share (mrq)4
Total debt (mrq)31.66B
Total debt/equity (mrq)73.09
Current ratio (mrq)1.39
Book value per share (mrq)17.07

Cash flow statement

Operating cash flow (ttm)18.89B
Levered free cash flow (ttm)10.3B